At a press conference in London, health officials said that the anticipated roll-out of the MenAfriVac for meningitis in three African countries will start on Dec. 6, the BBC reports. "The vaccine, which has been developed in India, costs less than fifty U.S. cents a dose and clinical tests suggest it could offer protection for between 10 and 15 years," the news service writes (Bowdler, 11/22)... 
More...
More...